Subcutaneous Injection Sites and Instructions for Safe Self Administration Peptide of the Week: Tirzepatide, a Game Changer for Type 2 Diabetes and Obesity Management Burick Center for Health and Wellness BPC 157 Dosing (Common Protocols), Oral Subcutaneous, 500 mcg daily, Duration: 6 weeks, Intramuscular Peritendinous, 1 mg daily, Duration: 6 weeks, Note:, Not approved by FDA or Too often, BPC 157 gets boxed into a single use: injury recovery. Gabriel Alizaidy, MD, MS What Is BPC 157? A Medical Clinic's Guide to the Body Protective Peptide, Its Uses, and What It Actually Does Perfect B